- Home
- VTR vs IDXX Comparison
VTR vs IDXX Comparison
Compare VTR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTR
- IDXX
- Stock Information
- Founded
- VTR 1983
- IDXX 1983
- Country
- VTR United States
- IDXX United States
- Employees
- VTR N/A
- IDXX N/A
- Industry
- VTR Real Estate Investment Trusts
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VTR Real Estate
- IDXX Health Care
- Exchange
- VTR Nasdaq
- IDXX Nasdaq
- Market Cap
- VTR 29.5B
- IDXX 34.1B
- IPO Year
- VTR 1998
- IDXX 1991
- Fundamental
- Price
- VTR $68.75
- IDXX $419.95
- Analyst Decision
- VTR Buy
- IDXX Buy
- Analyst Count
- VTR 10
- IDXX 8
- Target Price
- VTR $70.30
- IDXX $533.75
- AVG Volume (30 Days)
- VTR 3.4M
- IDXX 709.4K
- Earning Date
- VTR 04-30-2025
- IDXX 04-30-2025
- Dividend Yield
- VTR 2.79%
- IDXX N/A
- EPS Growth
- VTR N/A
- IDXX 6.06
- EPS
- VTR 0.19
- IDXX 10.67
- Revenue
- VTR $4,889,015,000.00
- IDXX $3,897,504,000.00
- Revenue This Year
- VTR $10.84
- IDXX $7.76
- Revenue Next Year
- VTR $9.06
- IDXX $8.05
- P/E Ratio
- VTR $361.84
- IDXX $39.35
- Revenue Growth
- VTR 9.46
- IDXX 6.46
- 52 Week Low
- VTR $41.45
- IDXX $398.50
- 52 Week High
- VTR $71.04
- IDXX $548.88
- Technical
- Relative Strength Index (RSI)
- VTR 59.04
- IDXX 44.56
- Support Level
- VTR $66.59
- IDXX $414.39
- Resistance Level
- VTR $68.54
- IDXX $424.17
- Average True Range (ATR)
- VTR 1.27
- IDXX 9.71
- MACD
- VTR -0.11
- IDXX 0.35
- Stochastic Oscillator
- VTR 83.11
- IDXX 60.05
About VTR Ventas Inc.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.